#research beam

Research Beam added report on “3-V Biosciences, Inc. - Product Pipeline Review - 2015”.

Summary

Global Markets Directs, ‘3-V Biosciences, Inc.  - Product Pipeline Review - 2015, provides an overview of the 3-V Biosciences Inc. s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of 3-V Biosciences Inc. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Enquiry @  http://www.researchbeam.com/3-v-biosciences-inc-product-pipeline-review-2015-market/enquire-about-report

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news and deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens RandD pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of 3-V Biosciences Inc.  including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of 3-V Biosciences Inc. s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the 3-V Biosciences Inc. s pipeline products

Reasons to buy

- Evaluate 3-V Biosciences Inc. s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of 3-V Biosciences Inc.  in its therapy areas of focus - Identify new drug targets and therapeutic classes in the 3-V Biosciences Inc. s RandD portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of 3-V Biosciences Inc.  and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of 3-V Biosciences Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of 3-V Biosciences Inc.  and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

TABLE OF CONTENTS

Table of Contents 2 List of Tables 4 List of Figures 4 3-V Biosciences, Inc. Snapshot 5 3-V Biosciences, Inc. Overview 5 Key Information 5 Key Facts 5 3-V Biosciences, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 3-V Biosciences, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 3-V Biosciences, Inc. - Pipeline Products Glance 10 3-V Biosciences, Inc. - Clinical Stage Pipeline Products 10 Phase I Products/Combination Treatment Modalities 10 3-V Biosciences, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 3-V Biosciences, Inc. - Drug Profiles 12 TVB-2640 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 Small Molecules to Inhibit Fatty Acid Synthase for Oncology 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 TVB-3567 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 3-V Biosciences, Inc. - Pipeline Analysis 15 3-V Biosciences, Inc. - Pipeline Products by Target 15 3-V Biosciences, Inc. - Pipeline Products by Route of Administration 16 3-V Biosciences, Inc. - Pipeline Products by Molecule Type 17 3-V Biosciences, Inc. - Pipeline Products by Mechanism of Action 18 3-V Biosciences, Inc. - Recent Pipeline Updates 19 3-V Biosciences, Inc. - Dormant Projects 21 3-V Biosciences, Inc. - Locations and Subsidiaries 22

Source @ http://www.researchbeam.com/3-v-biosciences-inc-product-pipeline-review-2015-market

About Us: We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports from our clients.

Research Beam added report on “Valneva SE - Product Pipeline Review - 2015”.

Summary

Global Markets Directs, ‘Valneva SE - Product Pipeline Review - 2015, provides an overview of the Valneva SEs pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Valneva SEs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Enquiry @  http://www.researchbeam.com/valneva-se-product-pipeline-review-2015-market/enquire-about-report

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news and deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens RandD pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Valneva SE including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Valneva SEs human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Valneva SEs pipeline products

Reasons to buy

- Evaluate Valneva SE s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Valneva SE in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Valneva SEs RandD portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Valneva SE and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Valneva SE - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Valneva SE and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

TABLE OF CONTENTS

Table of Contents 2 List of Tables 4 List of Figures 4 Valneva SE Snapshot 5 Valneva SE Overview 5 Key Information 5 Key Facts 5 Valneva SE - Research and Development Overview 6 Key Therapeutic Areas 6 Valneva SE - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Pipeline Products - Out-Licensed Products 12 Out-Licensed Products/Combination Treatment Modalities 13 Valneva SE - Pipeline Products Glance 14 Valneva SE - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Valneva SE - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Valneva SE - Drug Profiles 17 VLA-43 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Vaccine for Undisclosed Indication 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 VLA-84 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 VLA-15 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Antibodies for Pneumococcus Infections 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Valneva SE - Pipeline Analysis 23 Valneva SE - Pipeline Products by Target 23 Valneva SE - Pipeline Products by Route of Administration 24 Valneva SE - Pipeline Products by Molecule Type 25 Valneva SE - Recent Pipeline Updates 26 Valneva SE - Dormant Projects 30 Valneva SE - Discontinued Pipeline Products 31

Source @ http://www.researchbeam.com/valneva-se-product-pipeline-review-2015-market

About Us: We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports from our clients.

Research Beam added a report “Market Digest Cardiac Rhythm Management Devices 2006 to 2020-US and Europe (US, Germany, France, Italy, UK, Spain)”.

Summary

GBI Research's report, "Market Digest: Cardiac Rhythm Management Devices 2006 to 2020 US and Europe (US, Germany, France, Italy, UK, Spain)" provides quantitative analysis of the four cardiac rhythm management devices market segments: cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers. The analysis includes market size data by revenue and volume over the 2006-2020 period for the following countries: US, Germany, France, Italy, UK and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Enquiry @ http://www.researchbeam.com/digest-cardiac-rhythm-management-devices-2006-to-2020-us-and-europe-us-germany-france-italy-uk-spain-market/enquire-about-report

Scope • Information on market size for the four cardiac rhythm management devices market segments: : cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers

• Annualized sales data by revenue for the 2006-2020 period and company share data by revenue for 2013

• Annualized sales data by volume for the 2006-2020 period

• Coverage of key geographies: China US, Germany, France, Italy, UK and Spain

Reasons to buy

• Derive actionable insights from value-volume relationships

• Analyze value-volume relationships and provide direction to marketing and sales strategies

• Develop market-entry and market-expansion strategies

• Identify the key players best positioned to take advantage of opportunities in the US and European markets

Table Of Contents 1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 GBI Research Report Guidance 9

3 Definitions 9

3.1 Cardiac Rhythm Management Devices 9

3.2 Cardiac Resynchronization Therapy Devices 9

3.2.1 Cardiac Resynchronization Therapy - Defibrillators 9

3.2.2 Cardiac Resynchronization Therapy - Pacemakers 9

3.3 Implantable Cardioverter Defibrillators 9

3.3.1 Dual Chamber Implantable Cardioverter Defibrillators 9

3.3.2 Single Chamber Implantable Cardioverter Defibrillators 9

3.4 Implantable Loop Recorders 9

3.5 Pacemakers 9

3.5.1 Dual Chamber Pacemakers 9

3.5.2 Single Chamber Pacemakers 9

4 Cardiac Rhythm Management Devices Market, US, Revenue and Volume, 2006-2020 11

4.1 Cardiac Rhythm Management Devices Market, US, Revenue ($bn), 2006-2013 11

4.2 Cardiac Rhythm Management Devices Market, US, Revenue ($bn), 2013-2020 11

4.3 Cardiac Resynchronization Therapy Devices Market, US 12

4.3.1 Cardiac Resynchronization Therapy Devices Market, US, Revenue ($bn), 2006-2013 12

4.3.2 Cardiac Resynchronization Therapy Devices Market, US, Revenue ($bn), 2013-2020 12

4.3.3 Cardiac Resynchronization Therapy Devices Market, US, Volume (‘000), 2006-2013 13

4.3.4 Cardiac Resynchronization Therapy Devices Market, US, Volume (‘000), 2013-2020 13

4.4 Implantable Cardioverter Defibrillators Market, US 14

4.4.1 Implantable Cardioverter Defibrillators Market, US, Revenue ($bn), 2006-2013 14

4.4.2 Implantable Cardioverter Defibrillators Market, US, Revenue ($bn), 2013-2020 14

4.4.3 Implantable Cardioverter Defibrillators Market, US, Volume (‘000), 2006-2013 15

4.4.4 Implantable Cardioverter Defibrillators Market, US, Volume (‘000), 2013-2020 15

4.5 Implantable Loop Recorders Market, US 16

4.5.1 Implantable Loop Recorders Market, US, Revenue ($m), 2006-2013 16

4.5.2 Implantable Loop Recorders Market, US, Revenue ($m), 2013-2020 16

4.5.3 Implantable Loop Recorders Market, US, Volume (‘000), 2006-2013 17

4.5.4 Implantable Loop Recorders Market, US, Volume (‘000), 2013-2020 17

4.6 Pacemakers Market, US 18

4.6.1 Pacemakers Market, US, Revenue ($bn), 2006-2013 18

4.6.2 Pacemakers Market, US, Revenue ($bn), 2013-2020 18

4.6.3 Pacemakers Market, US, Volume (‘000), 2006-2013 19

4.6.4 Pacemakers Market, US, Volume (‘000), 2013-2020 19

4.7 Cardiac Rhythm Management Devices Market, US, Key Company Share by Revenue (%), 2013 20

5 Cardiac Rhythm Management Devices Market, Europe, Revenue, 2006-2020 21

5.1 Cardiac Rhythm Management Devices Market, Europe, Revenue ($bn), 2006-2013 21

5.2 Cardiac Rhythm Management Devices Market, Europe, Revenue ($bn), 2013-2020 21

6 Cardiac Rhythm Management Devices Market, Germany, Revenue and Volume, 2006-2020 23

6.1 Cardiac Rhythm Management Devices Market, Germany, Revenue ($bn), 2006-2013 23

6.2 Cardiac Rhythm Management Devices Market, Germany, Revenue ($bn), 2013-2020 23

6.3 Cardiac Resynchronization Therapy Devices Market, Germany 24

6.3.1 Cardiac Resynchronization Therapy Devices Market, Germany, Revenue ($m), 2006-2013 24

6.3.2 Cardiac Resynchronization Therapy Devices Market, Germany, Revenue ($m), 2013-2020 24

6.3.3 Cardiac Resynchronization Therapy Devices Market, Germany, Volume (‘000), 2006-2013 25

6.3.4 Cardiac Resynchronization Therapy Devices Market, Germany, Volume (‘000), 2013-2020 25

6.4 Implantable Cardioverter Defibrillators Market, Germany 26

6.4.1 Implantable Cardioverter Defibrillators Market, Germany, Revenue ($m), 2006-2013 26

6.4.2 Implantable Cardioverter Defibrillators Market, Germany, Revenue ($m), 2013-2020 26

6.4.3 Implantable Cardioverter Defibrillators Market, Germany, Volume (‘000), 2006-2013 27

6.4.4 Implantable Cardioverter Defibrillators Market, Germany, Volume (‘000), 2013-2020 27

6.5 Implantable Loop Recorders Market, Germany 28

6.5.1 Implantable Loop Recorders Market, Germany, Revenue ($m), 2006-2013 28

6.5.2 Implantable Loop Recorders Market, Germany, Revenue ($m), 2013-2020 28

6.5.3 Implantable Loop Recorders Market, Germany, Volume (‘000), 2006-2013 29

6.5.4 Implantable Loop Recorders Market, Germany, Volume (‘000), 2013-2020 29

6.6 Pacemakers Market, Germany 30

6.6.1 Pacemakers Market, Germany, Revenue ($m), 2006-2013 30

6.6.2 Pacemakers Market, Germany, Revenue ($m), 2013-2020 30

6.6.3 Pacemakers Market, Germany, Volume (‘000), 2006-2013 31

6.6.4 Pacemakers Market, Germany, Volume (‘000), 2013-2020 31

6.7 Cardiac Rhythm Management Devices Market, Germany, Key Company Share by Revenue (%), 2013 32

7 Cardiac Rhythm Management Devices Market, France, Revenue and Volume, 2006-2020 34

7.1 Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2006-2013 34

7.2 Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2013-2020 34

7.3 Cardiac Resynchronization Therapy Devices Market, France 35

7.3.1 Cardiac Resynchronization Therapy Devices Market, France, Revenue ($m), 2006-2013 35

7.3.2 Cardiac Resynchronization Therapy Devices Market, France, Revenue ($m), 2013-2020 35

7.3.3 Cardiac Resynchronization Therapy Devices Market, France, Volume (‘000), 2006-2013 36

7.3.4 Cardiac Resynchronization Therapy Devices Market, France, Volume (‘000), 2013-2020 36

7.4 Implantable Cardioverter Defibrillators Market, France 37

7.4.1 Implantable Cardioverter Defibrillators Market, France, Revenue ($m), 2006-2013 37

7.4.2 Implantable Cardioverter Defibrillators Market, France, Revenue ($m), 2013-2020 37

7.4.3 Implantable Cardioverter Defibrillators Market, France, Volume (‘000), 2006-2013 38

7.4.4 Implantable Cardioverter Defibrillators Market, France, Volume (‘000), 2013-2020 38

7.5 Implantable Loop Recorders Market, France 39

7.5.1 Implantable Loop Recorders Market, France, Revenue ($m), 2006-2013 39

7.5.2 Implantable Loop Recorders Market, France, Revenue ($m), 2013-2020 39

7.5.3 Implantable Loop Recorders Market, France, Volume (‘000), 2006-2013 40

7.5.4 Implantable Loop Recorders Market, France, Volume (‘000), 2013-2020 40

7.6 Pacemakers Market, France 41

7.6.1 Pacemakers Market, France, Revenue ($m), 2006-2013 41

7.6.2 Pacemakers Market, France, Revenue ($m), 2013-2020 41

7.6.3 Pacemakers Market, France, Volume (‘000), 2006-2013 42

7.6.4 Pacemakers Market, France, Volume (‘000), 2013-2020 42

7.7 Cardiac Rhythm Management Devices Market, France, Key Company Share by Revenue (%), 2013 43

Source: http://www.researchbeam.com/digest-cardiac-rhythm-management-devices-2006-to-2020-us-and-europe-us-germany-france-italy-uk-spain-market

About Us: We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports from our clients.

The report firstly introduced the Liquid Detergent basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Liquid Detergent industry; 3.) the North American Liquid Detergent industry; 4.) the European Liquid Detergent ndustry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

2014 Global Spinning Machine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Spinning Machine industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

Get Full Details On:

http://www.researchbeam.com/global-spinning-machine-industry-2014-research-report-market

2014 Global Battery Acid Industry Report is a professional and in-depth research report on the world’s major regional market conditions of the Battery Acid industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

Get Full Details On: http://www.researchbeam.com/global-battery-acid-industry-2014-research-report-market

Report Overview

2014 Global Soybean Milk Machine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Soybean Milk Machine industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

Get Full Details On: http://www.researchbeam.com/global-soybean-milk-machine-industry-2014-research-report-market

Report Overview

Research Beam adds a report titled “Global Wireless Chargers Market 2015-2019” that provides detailed information of the Global Wireless Chargers Market. The report is an excellent piece of study for investors who are looking towards the market.

Wireless charging is a process through which a device is charged without any connecting wires between the device and the power source. A wireless charger is required to facilitate wireless charging. Wireless charging is often confused with wireless power. The two terms revolve around the basic principle of having no connecting wires present between the device and the power source. The key difference, however, is that in wireless power, no intermediate device is required between the power source and the device, whereas in wireless charging, a wireless charger is required between the power source and the device that needs to be charged.

Get Full Details On: http://www.researchbeam.com/global-wireless-chargers-2015-2019-market